{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T16:50:18Z","timestamp":1776185418230,"version":"3.50.1"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:p>Hereditary alpha-tryptasemia (H<jats:italic>\u03b1<\/jats:italic>T) is an autosomal dominant genetic trait characterized by elevated basal serum tryptase due to increased TPSAB1 gene copy numbers. Affecting approximately 4%\u20136% of the Caucasian population, H<jats:italic>\u03b1<\/jats:italic>T is associated with mast cell-mediated symptoms, including cutaneous reactions, anaphylaxis, and functional gastrointestinal (GI) disorders. While the prevalence of H<jats:italic>\u03b1<\/jats:italic>T in various disorders of gut brain interaction (DGBI)is unknown, individuals with H<jats:italic>\u03b1<\/jats:italic>T exhibit GI disturbances. Mast cells, present throughout the GI tract, release mediators like histamine and prostaglandins, affecting gut motility, secretion, and permeability. Mast cell mediated activation of protease-activated receptors may contribute to gut barrier dysfunction, exacerbating the gastrointestinal symptoms. H<jats:italic>\u03b1<\/jats:italic>T-related GI symptoms are commonly misdiagnosed as other GI conditions, highlighting the need for increased awareness and further research into its pathophysiology and clinical impact. There are no randomized controlled trials on therapy for H<jats:italic>\u03b1<\/jats:italic>T mediated GI symptoms. Current treatment options are based on expert opinion, observational studies, and case reports. Effective therapies parallel those given for clonal mast cell disorders, primarily consisting of antihistamines and mast cell stabilizers. Further research is necessary to delineate the pathophysiology of H<jats:italic>\u03b1<\/jats:italic>T in the gastrointestinal tract so that targeted therapies may be developed. Herein, we aim to describe the pathophysiology, clinical manifestations, diagnostic features, and current\/future therapeutic options for patients suffering from H<jats:italic>\u03b1<\/jats:italic>T-mediated GI symptoms.<\/jats:p>","DOI":"10.3389\/falgy.2025.1598309","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T05:22:53Z","timestamp":1749532973000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Non allergic gastrointestinal manifestations of hereditary alpha-tryptasemia"],"prefix":"10.3389","volume":"6","author":[{"given":"Dylan","family":"Vainer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3238\/arztebl.m2023.0287","article-title":"The clinical features of hereditary alpha-tryptasemia-implications for interdisciplinary practice","volume":"121","author":"von Bubnoff","year":"2024","journal-title":"Dtsch Arztebl Int"},{"key":"B2","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.anai.2021.01.016","article-title":"Hereditary alpha-tryptasemia in 101 patients with mast cell activation-related symptomatology including anaphylaxis","volume":"126","author":"Giannetti","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/nmo.13070","article-title":"Tryptase potentiates enteric nerve activation by histamine and serotonin: relevance for the effects of mucosal biopsy supernatants from irritable bowel syndrome patients","volume":"29","author":"Ostertag","year":"2017","journal-title":"Neurogastroenterol Motil"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1007\/s10620-009-1094-8","article-title":"Subjects with diarrhea-predominant IBS have increased rectal permeability responsive to tryptase","volume":"55","author":"Lee","year":"2010","journal-title":"Dig Dis Sci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.iac.2018.04.011","article-title":"Mast cell mediators of significance in clinical practice in mastocytosis","volume":"38","author":"Butterfield","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"key":"B6","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1053\/j.gastro.2004.02.017","article-title":"Enteric neuroimmunophysiology and pathophysiology","volume":"127","author":"Wood","year":"2004","journal-title":"Gastroenterology"},{"key":"B7","first-page":"95","article-title":"Protease activated receptor 2: a new target for IBS treatment","volume":"12","author":"Bueno","year":"2008","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/j.1365-2982.2008.01139.x","article-title":"Protease-activated receptor 2 and gut permeability: a review","volume":"20","author":"Bueno","year":"2008","journal-title":"Neurogastroenterol Motil"},{"key":"B9","doi-asserted-by":"publisher","first-page":"382","DOI":"10.5009\/gnl14319","article-title":"Tryptase and protease-activated receptor 2 expression levels in irritable bowel syndrome","volume":"10","author":"Liang","year":"2016","journal-title":"Gut Liver"},{"key":"B10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.17235\/reed.2021.7697\/2020","article-title":"Irritable bowel syndrome and basal serum tryptase: correlation between subtype, severity, and comorbidities. A pilot study","volume":"114","author":"Ciriza de Los R\u00edos","year":"2022","journal-title":"Rev Esp Enferm Dig"},{"key":"B11","doi-asserted-by":"publisher","first-page":"362","DOI":"10.5858\/2006-130-362-MEIMMC","article-title":"Mastocytic enterocolitis: increased mucosal mast cells in chronic intractable diarrhea","volume":"130","author":"Jakate","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.3748\/wjg.v28.i29.3767","article-title":"Clinical challenge for gastroenterologists-gastrointestinal manifestations of systemic mastocytosis: a comprehensive review","volume":"28","author":"Elvevi","year":"2022","journal-title":"World J Gastroenterol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1053\/j.gastro.2016.03.035","article-title":"Rome IV-functional GI disorders: disorders of gut-brain interaction","volume":"150","author":"Drossman","year":"2016","journal-title":"Gastroenterology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/ng.3696","article-title":"Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number","volume":"48","author":"Lyons","year":"2016","journal-title":"Nat Genet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.jaci.2021.04.004","article-title":"Small intestinal immunopathology and GI-associated antibody formation in hereditary alpha-tryptasemia","volume":"148","author":"Konnikova","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.4049\/jimmunol.140.5.1581","article-title":"Effect of gangliosides on activation of the alternative pathway of human complement","volume":"140","author":"Michalek","year":"1988","journal-title":"J Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1007\/s10753-013-9664-5","article-title":"Mast cell tryptase induces eosinophil recruitment in the pleural cavity of mice via proteinase-activated receptor 2","volume":"36","author":"Matos","year":"2013","journal-title":"Inflammation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"6216","DOI":"10.4049\/jimmunol.159.12.6216","article-title":"Potent induction of a neutrophil and eosinophil-rich infiltrate in vivo by human mast cell tryptase: selective enhancement of eosinophil recruitment by histamine","volume":"159","author":"He","year":"1997","journal-title":"J Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.4049\/jimmunol.168.4.1992","article-title":"Tryptase inhibition blocks airway inflammation in a mouse asthma model","volume":"168","author":"Oh","year":"2002","journal-title":"J Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1164\/ajrccm.152.6.8520778","article-title":"Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheep","volume":"152","author":"Clark","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s10620-018-5298-7","article-title":"Elevated tryptase in EoE is an independent phenomenon associated with extra-esophageal symptoms","volume":"64","author":"Kutty","year":"2019","journal-title":"Dig Dis Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000541880","article-title":"Prevalence of autoantibodies in patients with hereditary alpha-tryptasemia","volume":"186","author":"Slapnicar","year":"2024","journal-title":"Int Arch Allergy Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jaci.2021.06.030","article-title":"Developing a standardized approach for assessing mast cells and eosinophils on tissue biopsies: a work group report of the AAAAI allergic skin diseases committee","volume":"148","author":"Zimmermann","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1097\/PAS.0000000000001676","article-title":"Distinct small intestine mast cell histologic changes in patients with hereditary alpha-tryptasemia and mast cell activation syndrome","volume":"45","author":"Hamilton","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"100005","DOI":"10.1016\/j.modpat.2022.100005","article-title":"What is the value of counting mast cells in gastrointestinal mucosal biopsies?","volume":"36","author":"Panarelli","year":"2023","journal-title":"Mod Pathol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S0889-8588(05)70301-4","article-title":"Treatment of systemic mast cell disorders","volume":"14","author":"Worobec","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"key":"B27","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.jaci.2021.06.017","article-title":"Hereditary alpha tryptasemia is not associated with specific clinical phenotypes","volume":"149","author":"Chollet","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B28","first-page":"721","article-title":"The effects of cromolyn sodium on the nasal mast cells","volume":"55","author":"Okuda","year":"1985","journal-title":"Ann Allergy"},{"key":"B29","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/0091-6749(90)90067-E","article-title":"Cromolyn sodium in the management of systemic mastocytosis","volume":"85","author":"Horan","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2500\/aap.2025.46.240102","article-title":"Exploring mast cell disorders: tryptases, hereditary alpha-tryptasemia, and MCAS treatment approaches","volume":"46","author":"Bellanti","year":"2025","journal-title":"Allergy Asthma Proc"},{"key":"B31","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/ajh.26118","article-title":"Systemic mastocytosis in adults: 2021 update on diagnosis, risk stratification and management","volume":"96","author":"Pardanani","year":"2021","journal-title":"Am J Hematol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1046\/j.1365-2982.2000.00221.x","article-title":"Increased mast cells in the irritable bowel syndrome","volume":"12","author":"O'Sullivan","year":"2000","journal-title":"Neurogastroenterol Motil"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1111\/j.1572-0241.1998.00531.x","article-title":"Are adverse food reactions linked to irritable bowel syndrome?","volume":"93","author":"Niec","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3389\/fimmu.2018.01067","article-title":"Effect of dietary fiber and metabolites on mast cell activation and mast cell-associated diseases","volume":"9","author":"Folkerts","year":"2018","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.iac.2020.06.007","article-title":"Targeting mast cells with biologics","volume":"40","author":"Lyons","year":"2020","journal-title":"Immunol Allergy Clin North Am"},{"key":"B36","doi-asserted-by":"publisher","first-page":"4759","DOI":"10.1172\/JCI138448","article-title":"Bruton\u2019s tyrosine kinase inhibition effectively protects against human IgE-mediated anaphylaxis","volume":"130","author":"Dispenza","year":"2020","journal-title":"J Clin Invest"},{"key":"B37","doi-asserted-by":"publisher","first-page":"242","DOI":"10.23822\/EurAnnACI.1764-1489.220","article-title":"Patients with elevated basal tryptase serum levels should be tested for hereditary alpha-tryptasemia","volume":"54","author":"Spoerl","year":"2022","journal-title":"Eur Ann Allergy Clin Immunol"}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2025.1598309\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T05:22:53Z","timestamp":1749532973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2025.1598309\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":37,"alternative-id":["10.3389\/falgy.2025.1598309"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2025.1598309","relation":{},"ISSN":["2673-6101"],"issn-type":[{"value":"2673-6101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"article-number":"1598309"}}